A Clinical Research of CD33-Targeted CAR-T in Myeloid Malignancies

Clinical trial NCT02958397 · UNKNOWN

Trial details

NCT number: NCT02958397
Sponsor: Southwest Hospital, China
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myeloid Malignancies

Start date: 2016-10-01
Primary completion: 2019-10-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.